Solid IO
ENDING THE GUESSWORK IN CANCER CARE | Patient-specific organ-on-chip technology for precision oncology & immunotherapy
8 employees · est. 2025 · Helsinki, Finland
Acrivon Therapeutics, Inc. is the older company (2018 vs 2025); Acrivon Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Acrivon Therapeutics, Inc. | Solid IO |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2025 |
| Headquarters | ||
| Headquarters | United States | Helsinki, Finland |
| Employees | ||
| Employees | 77 larger | 8 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Seed |
| Total Funding | ||
| Total Funding | $245.50M | $800.00K |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | Not tracked yet | Tumor-on-chip platform, Patient-specific treatment insights, Immunotherapy research support, Early-stage clinical trial facilitation |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotech Firms, Cancer Clinics, Oncologists, Researchers |
| Taxonomy | ||
| Taxonomy | Precision Oncology, Therapeutics, Proteomics, Patient Selection, Oncology Drug Targets, Clinical-stage Assets, Pipeline Development, Biomarker Discovery, Clinical Trials, Cancer Treatment, Drug Development, Boston Area, Lund, Sweden, Innovation | Organ-on-chip Technology, Precision Oncology, Immunotherapy, Tumor Microenvironment, Clinical Trials Optimization, Drug Development Acceleration, Biomarker Validation, Personalized Immunotherapies, Cancer Research, Patient-specific Treatment, Oncology Data Insights, Pharmaceutical Innovation, Biotech Collaboration, Precision Medicine |
| Website | ||
| Website | acrivon.com | solid-io.com |
About Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is a precision oncology therapeutics company with a unique proteomics-based patient selection platform. The company is focused on challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mut...
About Solid IO
Solid IO, founded in 2025 and headquartered in Finland, is pioneering advancements in precision oncology and immunotherapy through its unique organ-on-chip technology. The company's slogan, "ENDING THE GUESSWORK IN CANCER CARE," underscores its commitment to providing patient-specific data that empo...
We will tell you when either one moves
BounceWatch watches Acrivon Therapeutics, Inc. and Solid IO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Acrivon Therapeutics,... and Solid IO — by email.
Frequently Asked Questions
Compare Acrivon Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Acrivon Therapeutics, Inc. on 12 Sep 2024, and Solid IO on 13 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.